Skip to Content

08/31 Dynavax Technologies Corporation Shareholder Derivative Action- Preliminary Approval of Settlement

To: All current stockholders of Dynavax Technologies Corporation (NASDAQ: DVAX). The Superior Court of the State of California, County of Alameda, has granted preliminary approval for the settlement of certain derivative claims brought nominally for the benefit of Dynavax Technologies Corporation (Case No. RG13686266, styled Truglio v. Oronsky, et al).  A final hearing on the proposed settlement is scheduled for October 17, 2017 at 3:00 p.m., before the Honorable Brad Seligman, Department 30 in the Superior Court of the State of California, Alameda County, located at U.S. Post Office Building, 201 Thirteenth Street, Oakland, California 94613. For additional information, please see […]

08/02 Textura Corporation – Settlement Notice

To: All persons and/or entities who purchased common stock in Textura Corporation [TXTR] during the period from June 7, 2013 and January 7, 2014, and were damaged thereby; a settlement has been announced in the securities litigation known as Fred Kelsey v. Patrick J. Allin, et al., Case No. 14-cv-7837 (N.D.Ill.), United States District Court for the Northern District of Illinois. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is OCTOBER 23, 2017. If you […]

05/15 Akari Therapeutics, Plc [NASDAQ: AKTX]

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Akari Therapeutics, Plc Oklahoma City, OK (May 15, 2017) – On May 12, 2017, a securities class action lawsuit was filed in the United States District Court for the Southern District of New York against Akari Therapeutics, Plc (NASDAQ: AKTX). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the […]

05/11 Salix Pharmaceuticals, Ltd. – Settlement Notice

To: All persons and/or entities who purchased common stock in Salix Pharmaceuticals, Ltd. [SLXP] during the period from Nov 8, 2013 to Nov 6, 2014, and were damaged thereby; a settlement has been announced in the securities litigation known as In re Salix Pharmaceuticals, Ltd., Case No. 14 Civ. 8925 (KMW) , United States District Court for the Southern District of New York. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is AUGUST 9, […]

05/09 Vince Holding Corp. [NYSE: NVCE]

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Vince Holding Corp. Oklahoma City, OK (May 9, 2017) – On May 5, 2017, a securities class action lawsuit was filed in the United States District Court for the Eastern District of New York against Vince Holding Corp. (NYSE: VNCE). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the […]

05/04 KBR, Inc. [NYSE: KBR]

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against KBR, Inc. Oklahoma City, OK (May 4, 2017) – On May 3, 2017, a securities class action lawsuit was filed in the United States District Court for the Southern District of Texas against KBR, Inc. (NYSE: KBR). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which […]

05/04 Geron Corporation [GERN] – Settlement Notice

To: All persons and/or entities who purchased common stock in Geron Corporation [GERN] during the period from Dec 10, 2012 to Mar 11, 2014, and were damaged thereby; a settlement has been announced in the securities litigation known as Geron Corporation Securities. Litigation,  Civil Action No. 3:14-cv-01224-CRB, United States District Court for the Northern District of California. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is July 11, 2017. If you have any questions about […]

05/04 Energy Recovery, Inc. [ERII] – Settlement Notice

To: All persons and/or entities who purchased common stock in Energy Recovery [ERII] during the period from Mar 7, 2013 to Mar 5, 2015, and were damaged thereby; a settlement has been announced in the securities litigation known as Energy Recovery, Inc. Securities Litigation, Civil Action No. 3:15-cv-00265-EMC, United States District Court for the Northern District of California. For additional information about this settlement, please see the Notice and Proof of Claim (links provided below): Notice of Pendency and Proposed Settlement of Class Action and Settlement Fairness Hearing; Proof of Claim and Release. Claim submission deadline is August 4, 2017. If you have […]

04/18 Lion Biotechnologies, Inc. [NASDAQ: LBIO]

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Lion Biotechnologies, Inc. Oklahoma City, OK (April 18, 2017) – On April 14, 2017, a securities class action lawsuit was filed in the United States District Court for the Northern District of California against Lion Biotechnologies, Inc. (NASDAQ: LBIO). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class […]

04/17 U.S. Physical Therapy, Inc. [NYSE: USPH]

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against U.S. Physical Therapy, Inc. Oklahoma City, OK (April 17, 2017) – On March 31, 2017, a securities class action lawsuit was filed in the United States District Court for the Southern District of New York against U.S. Physical Therapy, Inc. (NYSE: USPH).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market […]

let’s connect

Click Here to Complete Federman & Sherwood Fee Agreement.

OKLAHOMA Office

10205 North Pennsylvania Avenue
Oklahoma City, Oklahoma 73120

TEXAS Office

212 W. Spring Valley Road,
Richardson, Texas 75081